TF
NVCR icon

Tompkins Financial’s NovoCure NVCR Stock Holding History

Tompkins Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$798 Hold
50
– – ﹤0.01% 549
2026
Q2 		$758 Hold
50
– – ﹤0.01% 538
2026
Q1 		$545 Hold
50
– – ﹤0.01% 548
2025
Q4 		$647 Hold
50
– – ﹤0.01% 614
2025
Q3 		$646 Hold
50
– – ﹤0.01% 530
2025
Q2 		$890 Hold
50
– – ﹤0.01% 524
2025
Q1 		$891 Sell
50
-50
-50% -$1.14K ﹤0.01% 539
2024
Q4 		$2.98K Hold
100
– – ﹤0.01% 482
2024
Q3 		$1.56K Hold
100
– – ﹤0.01% 541
2024
Q2 		$1.71K Hold
100
– – ﹤0.01% 548
2024
Q1 		$1.56K Hold
100
– – ﹤0.01% 583
2023
Q4 		$1.49K Hold
100
– – ﹤0.01% 601
2023
Q3 		$1.61K Hold
100
– – ﹤0.01% 544
2023
Q2 		$4.15K Hold
100
– – ﹤0.01% 526
2023
Q1 		$6.01K Hold
100
– – ﹤0.01% 522
2022
Q4 		$7K Hold
100
– – ﹤0.01% 510
2022
Q3 		$8K Hold
100
– – ﹤0.01% 496
2022
Q2 		$7K Hold
100
– – ﹤0.01% 497
2022
Q1 		$8K Buy
+100
New +$7.37K ﹤0.01% 505

Other funds holding NVCR

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Tompkins Financial's NVCR Position: Q3 2026 in Review

Tompkins Financial held its NovoCure (NVCR) position steady in Q3 2026 at 50 shares worth $798. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Tompkins Financial first reported a position in NVCR in Q1 2022 and has held it in 19 quarters since. The position peaked at $8K in Q3 2022. 15 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • Tompkins Financial held 50 shares of NovoCure worth $798 as of Q3 2026.
  • Tompkins Financial left its NovoCure share count unchanged in Q3 2026.
  • NovoCure made up ﹤0.01% of Tompkins Financial's portfolio in Q3 2026, its #549 holding.
  • Tompkins Financial first reported a position in NovoCure in Q1 2022 and has held it in 19 quarters since.
  • Tompkins Financial's NovoCure position peaked at $8K in Q3 2022.
  • 15 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on Tompkins Financial's 13F filing for Q3 2026, filed 5 Oct 2026.